Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C A BOUCHER

Showing results (201-210 of 254) with videos related to

Pageof 26
Sort By:
Antiviral Therapy|April 1, 1997
HIV-1 RNA levels in the cerebrospinal fluid may increase owing to damage to the blood-brain barrierD M Burger, C A Boucher, P L Meenhorst, et al.
American Heart Journal|December 1, 1986
Anterior ST segment depression in acute inferior myocardial infarction as a marker of greater inferior, apical, and posterolateral damageT D Ruddy, T Yasuda, H K Gold, et al.
The Journal of Antimicrobial Chemotherapy|February 14, 1998
In-vitro selection of HIV-1 variants resistant to non-nucleoside reverse transcriptase inhibitors in monocyte-derived macrophagesA M Been-Tiktak, C J de Haas, L de Graaf, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|January 1, 1997
Vertical HIV-1 transmission correlates with a high maternal viral load at deliveryO Coll, M Hernandez, C A Boucher, et al.
Lancet (London, England)|September 8, 1990
Zidovudine sensitivity of human immunodeficiency viruses from high-risk, symptom-free individuals during therapyC A Boucher, M Tersmette, J M Lange, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 6, 2001
Transient relapses ("blips") of plasma HIV RNA levels during HAART are associated with drug resistanceJ W Cohen Stuart, A M Wensing, C Kovacs, et al.
Annals of Internal Medicine|June 1, 1989
Combining clinical and thallium data optimizes preoperative assessment of cardiac risk before major vascular surgeryK A Eagle, C M Coley, J B Newell, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 15, 2000
The dominant source of CD4+ and CD8+ T-cell activation in HIV infection is antigenic stimulationJ W Cohen Stuart, M D Hazebergh, D Hamann, et al.
Circulation|May 1, 1983
Exercise testing in asymptomatic or minimally symptomatic aortic regurgitation: relationship of left ventricular ejection fraction to left ventricular filling pressure during exerciseC A Boucher, R A Wilson, D J Kanarek, et al.
Antimicrobial Agents and Chemotherapy|July 1, 1995
Safety, pharmacokinetics, and antiviral activity of A77003, a C2 symmetry-based human immunodeficiency virus protease inhibitorM Reedijk, C A Boucher, T van Bommel, et al.
Pageof 26

Showing results (201-210 of 254) with videos related to

Sort By:
Pageof 26
Antiviral Therapy|April 1, 1997
HIV-1 RNA levels in the cerebrospinal fluid may increase owing to damage to the blood-brain barrierD M Burger, C A Boucher, P L Meenhorst, et al.
American Heart Journal|December 1, 1986
Anterior ST segment depression in acute inferior myocardial infarction as a marker of greater inferior, apical, and posterolateral damageT D Ruddy, T Yasuda, H K Gold, et al.
The Journal of Antimicrobial Chemotherapy|February 14, 1998
In-vitro selection of HIV-1 variants resistant to non-nucleoside reverse transcriptase inhibitors in monocyte-derived macrophagesA M Been-Tiktak, C J de Haas, L de Graaf, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|January 1, 1997
Vertical HIV-1 transmission correlates with a high maternal viral load at deliveryO Coll, M Hernandez, C A Boucher, et al.
Lancet (London, England)|September 8, 1990
Zidovudine sensitivity of human immunodeficiency viruses from high-risk, symptom-free individuals during therapyC A Boucher, M Tersmette, J M Lange, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 6, 2001
Transient relapses ("blips") of plasma HIV RNA levels during HAART are associated with drug resistanceJ W Cohen Stuart, A M Wensing, C Kovacs, et al.
Annals of Internal Medicine|June 1, 1989
Combining clinical and thallium data optimizes preoperative assessment of cardiac risk before major vascular surgeryK A Eagle, C M Coley, J B Newell, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 15, 2000
The dominant source of CD4+ and CD8+ T-cell activation in HIV infection is antigenic stimulationJ W Cohen Stuart, M D Hazebergh, D Hamann, et al.
Circulation|May 1, 1983
Exercise testing in asymptomatic or minimally symptomatic aortic regurgitation: relationship of left ventricular ejection fraction to left ventricular filling pressure during exerciseC A Boucher, R A Wilson, D J Kanarek, et al.
Antimicrobial Agents and Chemotherapy|July 1, 1995
Safety, pharmacokinetics, and antiviral activity of A77003, a C2 symmetry-based human immunodeficiency virus protease inhibitorM Reedijk, C A Boucher, T van Bommel, et al.
Pageof 26